Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Ymera Pignochino(Candiolo Cancer Institute), Francesco Leone(Candiolo Cancer Institute)
Cited by 174
Related Papers
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
|Molecular Cancer|2009|176
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
|Molecular Cancer|2017|70
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient
|Tumor Biology|2015|40